Oppenheimer & Co. Inc. Boosts Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Oppenheimer & Co. Inc. grew its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 31.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,570 shares of the pharmacy operator’s stock after buying an additional 3,221 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Walgreens Boots Alliance were worth $127,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in WBA. First Financial Corp IN boosted its holdings in Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares during the last quarter. Golden State Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter worth $26,000. Venturi Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter worth $28,000. TD Private Client Wealth LLC boosted its stake in shares of Walgreens Boots Alliance by 8,670.3% during the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 3,208 shares during the last quarter. Finally, Brooklyn Investment Group purchased a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth $35,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA opened at $11.39 on Monday. The firm’s fifty day moving average is $10.64 and its two-hundred day moving average is $9.71. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05. The company has a market cap of $9.84 billion, a P/E ratio of -1.11, a P/E/G ratio of 1.31 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same period in the previous year, the firm posted $0.66 earnings per share. The business’s revenue was up 7.6% compared to the same quarter last year. As a group, analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on WBA shares. Evercore ISI lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Bank of America lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. Finally, Royal Bank of Canada lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $11.54.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.